S&P 500

5.277,51

0,80%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Precision Therapeutics Inc. (AIPT)
Precision Therapeutics Inc. (AIPT) Notícias

AIPT

Precision Therapeutics Inc. (AIPT)

Precision Therapeutics Inc.

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:AIPT

1 2 3 4 5 6 7 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
04/11/2019	08:05	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:AIPT	Precision Therapeutics Inc.
30/10/2019	07:20	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:AIPT	Precision Therapeutics Inc.
28/10/2019	09:31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AIPT	Precision Therapeutics Inc.
16/10/2019	17:39	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:AIPT	Precision Therapeutics Inc.
03/10/2019	17:54	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:AIPT	Precision Therapeutics Inc.
03/10/2019	17:51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AIPT	Precision Therapeutics Inc.
02/10/2019	15:35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:AIPT	Precision Therapeutics Inc.
01/10/2019	19:35	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:AIPT	Precision Therapeutics Inc.
30/09/2019	13:17	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:AIPT	Precision Therapeutics Inc.
26/09/2019	18:16	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:AIPT	Precision Therapeutics Inc.
18/09/2019	16:47	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:AIPT	Precision Therapeutics Inc.
17/09/2019	18:26	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:AIPT	Precision Therapeutics Inc.
19/08/2019	18:25	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AIPT	Precision Therapeutics Inc.
14/08/2019	18:11	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:AIPT	Precision Therapeutics Inc.
29/07/2019	11:09	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:AIPT	Precision Therapeutics Inc.
12/06/2019	09:00	GlobeNewswire Inc.	Predictive Oncology Inc. (Formerly Precision Therapeutics) Names Amelia Warner, Pharm.D., RPh, as Interim Chief Operating Off...	NASDAQ:AIPT	Precision Therapeutics Inc.
11/06/2019	09:00	GlobeNewswire Inc.	Precision Therapeutics Announces Corporate Name Change To Predictive Oncology Inc.	NASDAQ:AIPT	Precision Therapeutics Inc.
21/05/2019	09:00	GlobeNewswire Inc.	Precision Therapeutics’ Helomics Division Selected by AccuGenomics as Preferred Lab Partner for NIIMBL Grant	NASDAQ:AIPT	Precision Therapeutics Inc.
17/05/2019	10:00	GlobeNewswire Inc.	Precision Therapeutics Gains Extension for Nasdaq Compliance	NASDAQ:AIPT	Precision Therapeutics Inc.
15/05/2019	17:05	GlobeNewswire Inc.	Precision Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update	NASDAQ:AIPT	Precision Therapeutics Inc.
13/05/2019	14:30	GlobeNewswire Inc.	Precision Therapeutics to Report First Quarter 2019 Financial Results and Provide Company Update on Wednesday, May 15, 2019	NASDAQ:AIPT	Precision Therapeutics Inc.
24/04/2019	17:56	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:AIPT	Precision Therapeutics Inc.
18/04/2019	09:45	GlobeNewswire Inc.	Precision Therapeutics’ Subsidiary Helomics and National Alopecia Areata Foundation Sign Services Agreement to Provide Next...	NASDAQ:AIPT	Precision Therapeutics Inc.
16/04/2019	09:45	GlobeNewswire Inc.	Precision Therapeutics’ Subsidiary TumorGenesis and its Partner 48Hour Discovery Inc. Receive Alberta Innovates Product Dem...	NASDAQ:AIPT	Precision Therapeutics Inc.
11/04/2019	09:45	GlobeNewswire Inc.	Precision Therapeutics’ Subsidiary, Helomics® Corporation, and SpeciCare, Inc. to Study Innovative Personalized Medicine...	NASDAQ:AIPT	Precision Therapeutics Inc.
09/04/2019	09:45	GlobeNewswire Inc.	Precision Therapeutics’ Subsidiary Helomics to Collaborate with Viome to Explore the Impact of the Gut Microbiome on Ovaria...	NASDAQ:AIPT	Precision Therapeutics Inc.
08/04/2019	17:39	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:AIPT	Precision Therapeutics Inc.
05/04/2019	10:00	GlobeNewswire Inc.	Precision Therapeutics Announces Completion of Merger with Helomics Holding Corporation	NASDAQ:AIPT	Precision Therapeutics Inc.
03/04/2019	14:03	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:AIPT	Precision Therapeutics Inc.
02/04/2019	15:04	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:AIPT	Precision Therapeutics Inc.